Dexcom (DXCM) Change in Acquisitions & Divestments (2010 - 2026)

Dexcom (DXCM) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $525.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments fell 17.68% year-over-year to $525.8 million; the TTM figure through Jun 2026 stood at $1.9 billion (down 19.57% YoY), while the FY2025 annual figure was $2.2 billion, down 23.36% from the prior year.
• Change in Acquisitions & Divestments climbed to $525.8 million in Q2 2026 per DXCM's latest filing, from $468.2 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $1.1 billion in Q1 2024 and bottomed at $241.8 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $614.4 million across 5 years, with a median of $634.6 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 69.39% — and 2023, when it soared 188.5%.
• Dexcom's Change in Acquisitions & Divestments stood at $740.0 million in 2022, then declined by 2.84% to $719.0 million in 2023, then slumped by 43.64% to $405.2 million in 2024, then grew by 1.09% to $409.6 million in 2025, then climbed by 28.37% to $525.8 million in 2026.
• Business Quant data shows DXCM's Change in Acquisitions & Divestments at $525.8 million in Q2 2026, $468.2 million in Q1 2026, and $409.6 million in Q4 2025.